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1. Introduction 
It is well known that ethanol is oxidized to acetal- 
dehyde in the mammalian organism. Whether the 
symptoms of acute or chronic ethanol ingestion are 
caused exclusively by ethanol and acetaldehyde 
remains to be elucidated. Further pharmacodynami- 
tally active substances may be formed in the organism 
by other metabolic reactions, such as tetrahydro- 
harmane (THH), also known as eleagnin, which is the 
condensation product of acetaldehyde and trypta- 
mine. In principle the reaction occurs in vivo, since it 
was demonstrated in man and rat for tryptamine and 
5hydroxytryptamine with formaldehyde yielding 
tetrahydronorharmane and 6-hydroxytetrahydronor- 
harmane, respectively. 
Here, the existence of the /3-carbolines THH and 
harmane in the urine of man and rat is demonstrated. 
2. Materials and methods 
Female Wistar rats (200-220 g) received 8 ml 
0.9% NaCl orally in the evening and were kept individ- 
ually in a metabolic cage. The collection vessels con- 
tained 4 ml 1 N HCl and 200 1.11 of a solution of 
268.2 mg semicarbazide in 10 ml distilled water. The 
urine was collected over 12 h. Thereafter, the urine 
specimen was transferred to an Erlenmeyer flask 
saturated with dry NaCl, and adjusted to pH 10.2. 
The solution was shaken with 3-fold vol. diethylether. 
The ether had been saturated with water containing 
semicarbazide. The procedure was repeated with the 
same amount of ether. The two organic phases were 
combined and evaporated. The dry residue was dis- 
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solved in methanol (Merck, Darmstadt, p.a. grade). 
The compounds of the solution were separated by gel 
filtration on Sephadex G-25 (fine grade, Pharmacia, 
Freiburg). The elution medium consisted of 11.4 
mmol/l triethylamine (Merck) and 8 mmol/l acetic 
acid (Merck) in distilled water containing 10% 
methanol (v:v). The fractions were collected by a 
fraction collector (Ultrorac, LKB, Lochham). 
The retention times of THH and harmane had 
been measured by adding authentic substances (pur- 
chased from Ferak, Berlin and Sigma Chemie, 
Mtinchen) to rat urine. In the experiments performed 
to investigate the physiological occurrence of the /3- 
carbolines in the urine, the fractions with retention 
times similar to those of authentic THH and harmane, 
respectively, were collected and then lyophilized. The 
dry residue was dissolved in methanol (Uvasol-grade, 
Merck, Darmstadt) further separated by HPLC 
(Hewlett Packard, model 1084B) and analyzed by 
mass spectrometry. 
In a second experiment 8 rats were loaded with 
100 mg/kg tryptamine (Sigma Chemie) injected i.p. 
and 2 g/kg ethanol in 4 ml 0.9% NaCl/os 90 min later. 
The urine samples were collected, separated, and 
combined before the analysis by mass-spectrometry 
as above. 
In a third experiment 5 mg authentic THH (i.e., 
>103-times the amount detectable by mass-spectro- 
metry, l-3 pg) were added to the collection vial of 
the metabolic cage at the beginning of the collection 
period. The urine sample was treated as above and 
analyzed by mass-spectrometry. 
Human urine was investigated in the following way: 
Two male and two female volunteers which were not 
on diet, ingested either no ethanol or 30 g, or 100 g 
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ethanol mixed with orange juice in the evening hours. 
The urine was collected over 12 h into a glass cylinder 
containing 5ml 5 N HCl and 50 mg semicarbazide- 
HCl. The specimen (-750 ml) was lyophilized. The 
residue was dissolved in 100 ml distilled water. The 
solution was saturated with dry NaCl and adjusted to 
pH 10.2. Then, twice the amount of diethyleiher con- 
taining semicarbazide was added to the beaker. After 
shaking and centrifuging the organic phase was 
removed. The procedure was repeated once. The 
organic phases were combined and separated as de- 
scribed above for the rat urine. The sample was 
analyzed by mass-spe~tromet~. 
3. Results 
The urine of rats treated with saline was first 
analyzed by mass-spectrometry. No characteristic 
fragments of tetrahydronorharmane (THH) and har- 
mane were found under the conditions of mass-spec- 
trometry. Therefore, the experiments were repeated 
with rats loaded with 100 mg/kg tryptamine and 2 g 
ethanol. Under these conditions both, THH and har- 
mane, could be detected. The spectra were similar as 
those depicted in fig.2,3 for human urine. 
To exclude that the harmane detected in the urine 
sample is formed in vitro during the collection period, 
a urine specimen was assayed as usual but containing 
5 mg THH. No harmane could be detected by mass- 
spectrometry. 
Human urine was analyzed by ultraviolet spectro- 
metry as well as mass-spectrometry. Compounds of 
the urine sample of a subject loaded with 100 g etha- 
nol were separated by gel-ftitration and HPLC. The 
ultra~olet spectra of the authentic and extracted sub- 
stances are in good agreement (fig.1). 
In the upper part of fig.2, a mass-spectrum is 
depicted of authentic THH, in the lower part that of 
the extracted compound. The spectra show the char- 
acteristic peaks which can be expected from the 
fragmentation of the substance under the conditions 
of mass-spectrometry [l-3]. The peak of the mole- 
cule ion appears at m/z 186 with a medium relative 
intensity. Furthermore, asmaller peak (M-l) was 
found and the base-peak (M-l 5). Presumably both 
fragment ions are formed by emanation of a hydro- 
gen- and methyl-radical from the 1 -position in the 
course of an onium fission. The further fragmentation 
of the (M-l 5)ion m/z 171 under the elimination of 
HCN is proven by a meta-stable peak. 
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Caused by the substituent in position 1 the retro- 
Diels-Alder fragmentation is less pronounced com- 
pared with the fragmentation of THN (see f 111, 
fig.l,2). Instead of the base peak a signal at m/z 157 
can be detected of medium intensity followed by the 
loss of HCN and/or H’. For m/z 186+157+130-+103 
and m/z 156+129 the respective peaks are found in 
the mass-spectrum. 
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Fig.1. Ultraviolet spectrum of authentic THH (upper left) 
and the ultraviolet spectrum of a compound extracted from 
human urine separated by gel-filtration and HPLC (RP-8.7 
Hrn; elution conditions: isocratic, 30% acetonitriie, 70% 
acetic acid (8 mmolfl) and triethyiam~e (11 mmoljl, pH 8) 
upper right. The spectrum was recorded by the variable wave- 
length detector of the HPLC apparatus. UJtraviolet spec- 
trum of authentic harmane (lower left) and the ultraviolet 
spectrum of a second compound extracted from human urine 
separated and recorded as above (lower right). 
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Fig.2. ~~s~p~~trurn of authentic THN (upper part) and the 
spectrum of the compound extracted from human urine 
(lower part). ‘V’: contamination from the eluent. Conditions: 
Varian, MAT CH 7A, mass-spectrograph; 70 eV, 100°C. 
The mass-spectra ofauthentic harmane (upper part) 
and the compound extracted from the urine (lower 
part) are shown in fig.3. 
In contrast o THH the chemical structure of har- 
mane exhibits the maximal number of double bonds, 
Thus, the onium fission or the retro-~iels-Alder p o- 
cesses cannot further do~nate the fragmenta~on 
of the substance. Besides the mole&e ion peak @G/Z 
182) a relative pronounced peak at 18 1 can be 
demonstrated as a result of a tropylium-fission. The 
ions decay by elimination of II’ or Me’ or HCN and 
MeCN. In addition meta stable peaks are registered 
for FE/Z 182-+155+128. Thus, the spectra of authen- 
tic harmane and the extracted compound are in good 
agreement. 
However, in samples from individuals who had 
ingested no ethanol or 30 g ethanol none of the car- 
bolines was found. Thus, only a load with a high 
amount of ethanol eads to an excretion of conden- 
sation products in a concentration range large enough 
to be detected by mass-spectrometry (~3 pg). 
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Fig& mass-spectrum of authentic: harmane (upper part) and 
the spectrum of the compound extracted from human urine 
flower part). 
Acetaldehyde constitutes aphysiologically occur- 
ring substance in the mammalian organism. After 
ethanol ingestion it5 concentration i creases [4-71. 
Furthermore, tryptamine is found in the mammalian 
organism, too [S]. Therefore, it was of interest 
whether acetaldehyde and indoles react in viva by a 
Mannich reaction yielding fl-carbolines. Such a reaction 
was described to occur between tryptamine and for- 
maldehyde in man and rat 19-121 and between 5- 
hydraxyt~pt~~e and form~dehyde [13,14]. Here 
evidence is presented that the condensation product 
between tryptamine and acetafdehyde is excreted 
into the urine of man and rat after ethanol ingestion, 
The role of in vivo P-carbolines and other con- 
densation products in alcoholism remains to be 
elucidated. Condensation between aceta~dehyde and 
the catechofamines adrenaline and noradrenaline in
vitro was first described in [IS). After ingestion, this 
quinoline elicited excitation, drowsiness, halluci- 
nations, seizures, and changes of the blood pressure 
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[ 16,171. There is not yet a pharmacological study of 
THH. 
However, there are several reports dealing with 
harmane and with congeners of the two identified 
@carbolines. Harmane was tentatively found together 
with still other unidentified fl-carbolines in the nucleus 
arcuatus of rat brain [23]. Tetrahydronorharmane 
(THN), 6-OH-THN, 6-MeO-THN, and carbonyl- 
methyl-THN exert serotonergic activities and antag- 
onize the effects of dopamine-receptor stimulants 
[14,18-211. In combination with tetrahydropapa- 
veroline THN increases the voluntary ethanol inges- 
tion in rats [22]. Harmaline and harmane elicit 
excitation and euphoria in humans [24-261. The 
effects of harmaline in 30 volunteers were reported 
[27]. He observed autism and colorful hallucinations. 
In conclusion, despite the fact that only little is 
known about the significance of the two identified 
/I-carbolines, the available pharmacological data sup- 
port the view that the compounds may participate in 
the effects of ethanol. 
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